EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The use of thyroid hormones in the treatment of euthyroid patients with treatment-resistant depression. Data from a survey of 5695 European national endocrine professional organization members

Stephen Ludgate, Anne McGowan, Carla Moran, Roberto Attanasio, Miloš Žarković, Endre Vezekenyi Nagy, Roberto Negro, Enrico Papini, Chagit Adler Cohen, Ersin Akarsu, Maria Alevizaki, Göksun Ayvaz und 48 weitere

Frontiers in Endocrinology · 2025

DOI: 10.3389/fendo.2025.1665720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Endocrinology, 2025. Verfasst von Stephen Ludgate und 59 weiteren Autor:innen. Beteiligte Einrichtung: The School of Medicine, Trinity College Dublin, The University of Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Thyroid Hormones, Depressive Disorder, Treatment-Resistant, Hypothyroidism, Practice Patterns, Physicians'. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Treatment-resistant depression (TRD) is most commonly defined as depression that has not responded to two different pharmacological agents used for an adequate period of time. We explored the views of European specialists via survey, regarding the use of thyroid hormone (TH) in euthyroid patients with TRD as part of ‘Treatment of Hypothyroidism in Europe by Specialists: An International Survey’ (THESIS).

Methods

The question “Thyroid hormones may be indicated in biochemically euthyroid patients with treatment resistant depression” was posed to specialists from 28 countries.

Results

5695 valid responses were received following 17,232 invitations (33.0% response rate; 65% female, 90% endocrinologists). 348 (6.1%) stated that TH may be indicated in biochemically euthyroid patients with TRD. This view was more common in males (p<0.01), respondents who saw ≥100 patients with hypothyroidism per year (p<0.01), respondents who worked in private practice (p=0.05) and respondents who were not members of international specialist associations (p=0.05). Geographical variation existed with respondents in Eastern Europe significantly more likely to use TH in TRD (p<0.01). Linear regression showed a statistically significant reduction in the use of TH for TRD with increasing gross national income (F-statistic=7.35, CI -0.15 - -0.02, p=0.01). TH in TRD was recommended in psychiatry guidelines but not endocrinology guidelines.

Conclusion

While there is limited evidence for their use, over 6% of respondents stated that TH may be indicated in TRD. Due to the risk of iatrogenic thyrotoxicosis and increased morbidity the use of TH should be addressed in relevant endocrinology guidelines and consensus should be reached between specialties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid HormonesDepressive Disorder, Treatment-ResistantHypothyroidismPractice Patterns, Physicians'HumansFemaleMaleEuropeSurveys and QuestionnairesEndocrinologistsAdultMiddle AgedEndocrinology

Stichwörter der Autor:innen

TRD (treatment-resistant depression)levothyroxineliothyroininethyroidthyroid hormone

Substanzen

Thyroid Hormones

Autor:innen und Institutionen

  • The School of Medicine, Trinity College Dublin, The University of Dublin, Dublin, Ireland.
  • Robert Graves Institute, Tallaght University Hospital, Dublin, Ireland.
  • Diabetes and Endocrinology Section, Beacon Hospital, Dublin, Ireland.
  • School of Medicine, University College Dublin, Dublin, Ireland.
  • Endocrine Department, St Vincent's University Hospital, Dublin, Ireland.
  • Scientific Committee Associazione Medici Endocrinologi, Udine, Italy.

Zitieren

APA

Ludgate, S., McGowan, A., Moran, C., Attanasio, R., Žarković, M., Nagy, E. V., Negro, R., Papini, E., Adler Cohen, C., Akarsu, E., Alevizaki, M., Ayvaz, G., Bednarczuk, T., Beleslin, B. N., Berta, E., Bodor, M., Borissova, A. M., Boyanov, M., Buffet, C., …, & Hegedüs, L. (2025). The use of thyroid hormones in the treatment of euthyroid patients with treatment-resistant depression. Data from a survey of 5695 European national endocrine professional organization members. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2025.1665720

Vancouver

Ludgate S, McGowan A, Moran C, Attanasio R, Žarković M, Nagy EV, et al. The use of thyroid hormones in the treatment of euthyroid patients with treatment-resistant depression. Data from a survey of 5695 European national endocrine professional organization members. Frontiers in Endocrinology. 2025. doi:10.3389/fendo.2025.1665720

BibTeX
@article{Ludgate2025,
  author = {Ludgate, Stephen and McGowan, Anne and Moran, Carla and Attanasio, Roberto and Žarković, Miloš and Nagy, Endre Vezekenyi and Negro, Roberto and Papini, Enrico and Adler Cohen, Chagit and Akarsu, Ersin and Alevizaki, Maria and Ayvaz, Göksun and Bednarczuk, Tomasz and Beleslin, Biljana Nedeljković and Berta, Eszter and Bodor, Miklos and Borissova, Anna Maria and Boyanov, Mihail and Buffet, Camille and Burlacu, Maria-Cristina and Ćirić, Jamina and Díez, Juan J and Dobnig, Harald and Fadeyev, Valentin and Field, Benjamin C T and Fliers, Eric and Führer-Sakel, Dagmar and Galofré, Juan Carlos and Hakala, Tommi and Jiskra, Jan and Kopp, Peter A and Krebs, Michael and Kršek, Michal and Kužma, Martin and Lazúrová, Ivica and Leenhardt, Laurence and Luchytskiy, Vitaliy and Melo, Miguel and Metso, Saara and Morgunova, Tatyana and Niculescu, Dan Alexandru and Perić, Božidar and Planck, Tereza and Poiana, Catalina and Marques Puga, Francisca and Robenshtok, Eyal and Rosselet, Patrick and Ruchala, Marek and Riis, Kamilla Ryom and Shepelkevich, Alla and Tronko, Mykola D and Frølich, Jacob Stampe and Unuane, David and Vardarli, Irfan and Visser, W Edward and Vryonidou, Andromachi and Younes, Younes Ramazan and Yurenya, Elena and Perros, Petros and Hegedüs, Laszlo},
  title = {The use of thyroid hormones in the treatment of euthyroid patients with treatment-resistant depression. Data from a survey of 5695 European national endocrine professional organization members},
  journal = {Frontiers in Endocrinology},
  year = {2025},
  doi = {10.3389/fendo.2025.1665720}
}
Kostenlos starten →